Cubist Systematic Strategies, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 297 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$836,486
-45.9%
104,3000.0%0.01%
-33.3%
Q1 2024$1,545,726
-59.4%
104,300
-77.8%
0.01%
-64.0%
Q4 2023$3,811,515
+114.3%
468,821
+85.6%
0.02%
+108.3%
Q2 2023$1,778,459
-41.4%
252,622
-49.2%
0.01%
-36.8%
Q1 2023$3,036,542
-23.1%
496,979
-19.5%
0.02%
-17.4%
Q4 2022$3,946,598
-9.9%
617,621
+35.2%
0.02%
-8.0%
Q3 2022$4,378,000
+46.8%
456,947
+69.1%
0.02%
+38.9%
Q2 2022$2,983,000
-16.9%
270,238
+25.3%
0.02%
-40.0%
Q1 2022$3,590,000
+0.1%
215,645
+14.8%
0.03%
-11.8%
Q4 2021$3,585,000
-43.1%
187,785
-26.4%
0.03%
-57.0%
Q3 2021$6,296,000
+23218.5%
255,299
+24400.9%
0.08%
Q2 2021$27,000
-99.1%
1,042
-98.9%
0.00%
-100.0%
Q1 2021$3,123,000
+144.4%
98,642
+258.3%
0.04%
+122.2%
Q4 2020$1,278,000
+34.5%
27,534
-4.6%
0.02%
+28.6%
Q3 2020$950,000
-88.0%
28,851
-90.0%
0.01%
-89.8%
Q2 2020$7,903,000
+1219.4%
287,903
+1231.2%
0.14%
+1145.5%
Q4 2019$599,000
-39.1%
21,628
-60.0%
0.01%
-45.0%
Q3 2019$984,000
+720.0%
54,067
+1000.3%
0.02%
+900.0%
Q2 2019$120,000
-43.1%
4,914
-77.8%
0.00%
-71.4%
Q1 2019$211,000
+66.1%
22,150
+54.0%
0.01%
+16.7%
Q4 2018$127,000
-47.3%
14,385
+0.7%
0.01%
-57.1%
Q1 2018$241,00014,2840.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders